AML Insights – December Update: What’s New in the Field

Stay up to date with the latest advances in acute myeloid leukemia (AML), from lncRNA- and epigenetic-targeted therapies to MRD-guided treatment, menin- and FLT3/NPM1-directed strategies, as well as innovative transplant- and cellular-based approaches.
Don’t miss these exciting developments!